- Home
- NPFD vs EBS Comparison
NPFD vs EBS Comparison
Compare NPFD & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPFD
- EBS
- Stock Information
- Founded
- NPFD 2021
- EBS 1998
- Country
- NPFD United States
- EBS United States
- Employees
- NPFD N/A
- EBS N/A
- Industry
- NPFD Trusts Except Educational Religious and Charitable
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- NPFD Finance
- EBS Health Care
- Exchange
- NPFD Nasdaq
- EBS Nasdaq
- Market Cap
- NPFD 456.7M
- EBS 459.6M
- IPO Year
- NPFD N/A
- EBS 2006
- Fundamental
- Price
- NPFD $18.86
- EBS $9.40
- Analyst Decision
- NPFD
- EBS Strong Buy
- Analyst Count
- NPFD 0
- EBS 2
- Target Price
- NPFD N/A
- EBS $14.00
- AVG Volume (30 Days)
- NPFD 64.7K
- EBS 1.6M
- Earning Date
- NPFD 01-01-0001
- EBS 11-06-2024
- Dividend Yield
- NPFD 6.28%
- EBS N/A
- EPS Growth
- NPFD N/A
- EBS N/A
- EPS
- NPFD N/A
- EBS N/A
- Revenue
- NPFD N/A
- EBS $1,125,500,000.00
- Revenue This Year
- NPFD N/A
- EBS $7.98
- Revenue Next Year
- NPFD N/A
- EBS $6.62
- P/E Ratio
- NPFD N/A
- EBS N/A
- Revenue Growth
- NPFD N/A
- EBS 2.05
- 52 Week Low
- NPFD $14.50
- EBS $1.42
- 52 Week High
- NPFD $18.07
- EBS $15.10
- Technical
- Relative Strength Index (RSI)
- NPFD 48.56
- EBS 50.73
- Support Level
- NPFD $18.35
- EBS $8.12
- Resistance Level
- NPFD $19.30
- EBS $12.68
- Average True Range (ATR)
- NPFD 0.26
- EBS 0.91
- MACD
- NPFD -0.01
- EBS -0.18
- Stochastic Oscillator
- NPFD 50.69
- EBS 33.67
About NPFD Nuveen Variable Rate Preferred & Income Fund
Nuveen Variable Rate Preferred&Income is a newly organized, diversified, closed-end management investment company. The Fund's investment objective is to seek to provide a high level of current income and total return.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.